The IRA Has Improved Coverage of Drugs Selected for Medicare Price Negotiation

(Authors: Juliette Cubanski and Nolan Sroczynski for The Kaiser Family Foundation Published: Feb 11, 2026)

The Medicare Drug Price Negotiation Program, enacted as part of the Inflation Reduction Act of 2022 (IRA), was designed to help lower Medicare spending on prescription drugs by requiring the federal government to negotiate the price of some high-cost drugs covered by Medicare. Along with lowering prices, the negotiation program could also improve coverage of drugs selected for negotiation for Medicare beneficiaries because the law requires all Medicare Part D plans to cover each of the selected drugs, including all dosages and forms, when negotiated prices take effect. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.